PURPOSE: Gene expression array analysis is providing key data on the potential candidate genes and biological pathways involved in schwannoma origin and development. In this way we performed expression array studies on tumor-related genes in schwannomas. METHODS: The GE Array Q Series HS-006 (SuperArray, Bethesda, MD, USA) was used to determine the expression levels of 96 genes corresponding to 6 primary biological regulatory pathways in a series of 23 schwannomas. RESULTS: We identified 15 genes down-regulated, primarily corresponding to signal transduction functions, and 26 genes up-regulated, most frequently involving cell adhesion functions. CONCLUSIONS: In addition to the NF2 inactivation (considered as an early step), variations of other biological regulatory pathways might play a key role in schwannoma.
PURPOSE: Gene expression array analysis is providing key data on the potential candidate genes and biological pathways involved in schwannoma origin and development. In this way we performed expression array studies on tumor-related genes in schwannomas. METHODS: The GE Array Q Series HS-006 (SuperArray, Bethesda, MD, USA) was used to determine the expression levels of 96 genes corresponding to 6 primary biological regulatory pathways in a series of 23 schwannomas. RESULTS: We identified 15 genes down-regulated, primarily corresponding to signal transduction functions, and 26 genes up-regulated, most frequently involving cell adhesion functions. CONCLUSIONS: In addition to the NF2 inactivation (considered as an early step), variations of other biological regulatory pathways might play a key role in schwannoma.
Authors: T Kino; H Takeshima; M Nakao; T Nishi; K Yamamoto; T Kimura; Y Saito; M Kochi; J Kuratsu; H Saya; Y Ushio Journal: Genes Cells Date: 2001-05 Impact factor: 1.891
Authors: M Josefa Bello; Victor Martinez-Glez; Carmen Franco-Hernandez; Carolina Pefla-Granero; Jose M de Campos; Alberto Isla; Luis Lassaletta; Jesus Vaquero; Juan A Rey Journal: Cancer Genet Cytogenet Date: 2007-01-01
Authors: M J Bello; J M de Campos; M E Kusak; J Vaquero; J L Sarasa; A Pestaña; J A Rey Journal: Genes Chromosomes Cancer Date: 1993-04 Impact factor: 5.006
Authors: J Antinheimo; S L Sallinen; P Sallinen; H Haapasalo; H Helin; N Horelli-Kuitunen; M Wessman; M Sainio; J Jääskeläinen; O Carpén Journal: Acta Neurochir (Wien) Date: 2000 Impact factor: 2.216
Authors: Victor Martínez-Glez; Luis Alvarez; Carmen Franco-Hernández; Miguel Torres-Martin; Jose M de Campos; Alberto Isla; Jesús Vaquero; Luis Lassaletta; Javier S Castresana; Cacilda Casartelli; Juan A Rey Journal: Cancer Genet Cytogenet Date: 2010-01-01
Authors: Pilar Gonzalez-Gomez; M Josefa Bello; M Eva Alonso; Jesus Lomas; Dolores Arjona; Jose M de Campos; Jesus Vaquero; Alberto Isla; Luis Lassaletta; Manuel Gutierrez; Jose L Sarasa; Juan A Rey Journal: Clin Cancer Res Date: 2003-11-15 Impact factor: 12.531
Authors: P E Leone; M J Bello; M Mendiola; M E Kusak; J M De Campos; J Vaquero; J L Sarasa; A Pestana; J A Rey Journal: Int J Mol Med Date: 1998-05 Impact factor: 4.101
Authors: Miguel Torres-Martin; Luis Lassaletta; Alberto Isla; Jose M De Campos; Giovanny R Pinto; Rommel R Burbano; Javier S Castresana; Barbara Melendez; Juan A Rey Journal: Oncol Rep Date: 2014-10-03 Impact factor: 3.906
Authors: Miguel Torres-Martin; Luis Lassaletta; Jose M de Campos; Alberto Isla; Javier Gavilan; Giovanny R Pinto; Rommel R Burbano; Farida Latif; Barbara Melendez; Javier S Castresana; Juan A Rey Journal: PLoS One Date: 2013-06-11 Impact factor: 3.240
Authors: Miguel Torres-Martín; Victor Martinez-Glez; Carolina Peña-Granero; Alberto Isla; Luis Lassaletta; Jose M DE Campos; Giovanny R Pinto; Rommel R Burbano; Bárbara Meléndez; Javier S Castresana; Juan A Rey Journal: Oncol Lett Date: 2013-05-23 Impact factor: 2.967